Villabeto, Roxan D.

HRN: 04-16-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2022
CEFUROXIME 1.5GM (VIAL)
05/06/2022
05/06/2022
IV
1.5g
Once
For Repeat CS
Waiting Final Action 
05/06/2022
CEFUROXIME 750MG (VIAL)
05/06/2022
05/12/2022
IV
750mg
Q8h
For Repeat Cs
05/08/2022
CEFUROXIME 500MG (TAB)
05/08/2022
05/14/2022
PO
500mg
BID
S/P LP CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: